Planned Change in Procurement Expenditure in the Pharmaceutical Industry - 2012–2013 : Survey Snapshot

Synopsis

• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides analysis on planned change in procurement expenditure in the pharmaceutical industry.

Summary

This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how annual procurement budgets are set to change in the pharmaceutical industry in 2012–13. The report also provides access to information categorized by region, company type and size.

Scope

• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global – drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• This report covers data and analysis on planned change in procurement expenditure in the pharmaceutical industry.

Reasons To Buy

• This report will help you understand planned change in procurement expenditure in the global pharmaceuticals industry by buyer type.
• This report will help you understand planned change in procurement expenditure in the global pharmaceuticals industry by region.
• This report will help you understand planned change in procurement expenditure by in the global pharmaceuticals industry turnover.